Results 91 to 100 of about 8,684 (266)
The aim of this study is to present the problems that may be raised by the translation of proper names on different levels of context, and the methods with which translators can solve these issues.
Vermes, Albert
doaj
A tanulmányban a szerző arra tesz kísérletet, hogy Magyarországnak az euró bevezetésével kapcsolatos halogató magatartását egy rendszerszemléletű megközelítésen keresztül értelmezze. A makrogazdasági (in)stabilitás kérdését interdiszciplináris megközelítéssel tárgyalja, amelynek során olyan területek releváns ismereteire támaszkodik, mint a fejlődéstan,
openaire +1 more source
Objective To assess guselkumab + golimumab combination therapy versus guselkumab monotherapy in participants with active psoriatic arthritis (PsA) and inadequate response to tumor necrosis factor inhibitors (TNFi‐IR). Methods Adults with active TNFi‐IR PsA (three or more tender/swollen joints) were randomized (2:1) to subcutaneous guselkumab (100 mg) +
Jose U. Scher +12 more
wiley +1 more source
Occupational names can be regarded as one of the most characteristic types of Hungarian family names: 10 out of the 20 most frequent family names in the stock of contemporary surnames belong to this category.
Slíz, Marianna Ilona
doaj
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
The paper examines the Foundation Deed of Százd Abbey, an important, albeit until recently neglected, 11th-century linguistic record as a source for historical linguistics.
Kovács, Éva
doaj
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
The paper examines the names of dishes on Hungarian gastronomy blogs from a linguistic point of view. The author has collected 1380 names from one hundred blogs and collections of recipes on the Internet.
Török, Katalin
doaj
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source

